Plasmodium falciparum resistance to artemisinin derivatives in southeast Asia threatens malaria control and elimination activities worldwide. To monitor the spread of artemisinin resistance, a molecular marker is urgently needed. Here, using whole-genome sequencing of an artemisinin-resistant parasite line from Africa and clinical parasite isolates from Cambodia, we associate mutations in the PF3D7_1343700 kelch propeller domain ('K13-propeller') with artemisinin resistance in vitro and in vivo. Mutant K13-propeller alleles cluster in Cambodian provinces where resistance is prevalent, and the increasing frequency of a dominant mutant K13-propeller allele correlates with the recent spread of resistance in western Cambodia. Strong correlations between the presence of a mutant allele, in vitro parasite survival rates and in vivo parasite clearance rates indicate that K13-propeller mutations are important determinants of artemisinin resistance. K13-propeller polymorphism constitutes a useful molecular marker for large-scale surveillance efforts to contain artemisinin resistance in the Greater Mekong Subregion and prevent its global spread.
, or a persistence of microscopically detectable parasites on the third day of artemisininbased combination therapy (ACT) 2 . The half-life parameter correlates strongly with results from the in vitro ring-stage survival assay (RSA 0-3 h ) and results from the ex vivo RSA 13 , which measure the survival rate of young ring-stage parasites to a pharmacologically relevant exposure (700 nM for 6 h) to dihydroartemisinin (DHA)-the major metabolite of all ARTs. However, the present lack of a molecular marker hampers focused containment of ART-resistant parasites in areas where they have been documented and hinders rapid detection of these parasites elsewhere, where ACTs remain the most affordable, effective antimalarials. To detect and monitor the spread of ART resistance, a molecular marker for widespread use is needed.
Recent genome-wide analyses of P. falciparum isolates have provided evidence of recent positive selection in geographic areas of ART resistance 9, [14] [15] [16] . Whereas parasite heritability of the clinical phenotype is above 50%, no reliable molecular marker has yet been identified. One possible explanation is that the parasite clearance half-life is not only determined by the intrinsic susceptibility of a parasite isolate to ART, but also by its developmental stage at the time of ART treatment and host-related parameters such as pharmacokinetics and immunity 17 . This issue was recently highlighted in patients presenting discordant data between parasite clearance half-life in vivo and RSA 0-3 h survival rate in vitro 13 . Moreover, genome-wide association studies (GWAS) are confounded by uncertainties about parasite population structure. Recent evidence for several highly differentiated subpopulations of ARTresistant parasites in western Cambodia 15 suggests that distinct emergence events might be occurring. An alternative strategy to discover a molecular marker is to analyse mutations acquired specifically by laboratory-adapted parasite clones selected to survive high doses of ART in vitro, and use this information to guide analysis of polymorphism in clinical parasite isolates from areas where ART resistance is well documented at both temporal and geographical levels. Here we used this strategy to explore the molecular signatures of clinical ART resistance in Cambodia, where this phenotype was first reported 1, 8 .
A candidate molecular marker of ART resistance
The ART-resistant F32-ART5 parasite line was selected by culturing the ART-sensitive F32-Tanzania clone under a dose-escalating, 125-cycle regimen of artemisinin for 5 years 18 . Whole-genome sequences were obtained for both F32-ART5 and F32-TEM (its sibling clone cultured without artemisinin) at 4603 and 5003 average nucleotide coverage, respectively. Compared to F32-TEM, no deleted genes were identified in F32-ART5. The exomes of F32-ART5 and F32-TEM were compared after excluding (1) genes from highly variable, multi-gene families (var, rifin and stevor), (2) positions with coverage lower than 25% of the mean coverage of the parasite line, (3) single-nucleotide polymorphisms (SNPs) found to be mixed in F32-ART5, given that acquired ART-resistance mutation(s) could be expected to be fixed in the sample after 5 years of continuous pressure, (4) SNPs shared between F32-ART5 and the ART-sensitive 3D7 parasite strain and (5) synonymous SNPs (Extended Data Fig. 1 ).
This analysis identified eight mutations in seven genes that were subsequently confirmed by Sanger sequencing of PCR products (Extended Data Table 1 ). Each gene harbours one mutant codon in F32-ART5 compared to F32-TEM, F32-Tanzania or 3D7 (Extended Data Table 2 ). Information on the expression of the genes and the biological function of the proteins are listed in Extended Data Table 3 . Only one of these genes, cysteine protease falcipain 2a (PF3D7_1115700), has previously been associated with in vitro responses to ART 19 . To determine when each mutation arose in the F32-ART5 lineage, we analysed the wholegenome sequences of parasites at various drug-pressure cycles (Fig. 1 ). This analysis showed that the PF3D7_0110400 D56V and PF3D7_ 1343700 M476I mutations were acquired first, during the steep increase of ART resistance, and remained stable thereafter. Importantly, the appearance of these two mutations is associated with an increase in the RSA 0-3 h survival rate, from less than 0.01% to 12.8%. Subsequent PCR analysis of the PF3D7_1343700 locus detected the M476I mutation after 30 drug-pressure cycles, consistent with the sharp increase in RSA 0-3 h survival rate observed thereafter. The other SNPs appeared stepwise at later stages of selection: PF3D7_0213400 (68 cycles); PF3D7_ 1115700 (98 cycles); PF3D7_1302100, PF3D7_1459600 and PF3D7_ 1464500 (120 cycles) (Extended Data Table 2 ). These data indicate that the PF3D7_1343700 M476I mutation increased the resistance of F32-Tanzania to DHA in the RSA 0-3 h .
To explore whether these mutations are associated with ART resistance in Cambodia, we investigated sequence polymorphism in all seven genes by mining whole-genome or Sanger sequences for 49 cultureadapted parasite isolates collected in 2010-2011 (see Methods). We chose these isolates based on their differential RSA 0-3 h survival rates (Supplementary Table 1 ) and their sequences were compared to those of control parasites lines 3D7, 89F5 20 and K1992 (see Methods). Three genes (PF3D7_0110400, PF3D7_0213400 and PF3D7_1302100) encode a wild-type sequence for all parasite isolates. The other four genes show intra-population diversity, with previously reported or novel SNPs (Supplementary Table 1 ). PF3D7_1115700 has 11 SNPs that are not associated with RSA 0-3 h survival rates (P 5 0.06, Kruskal-Wallis test). PF3D7_1459600 has 6 SNPs that are not associated with survival rates (P 5 0.65). PF3D7_1464500 has 12 SNPs previously reported in older isolates from southeast Asia, including the ART-susceptible Dd2 line 21 , probably reflecting a geographic signature. These SNPs also show no significant association with survival rates (P 5 0.42). Therefore, these six genes were not studied further.
In contrast, PF3D7_1343700 polymorphism shows a significant association with RSA 0-3 h survival rates (Fig. 2) . Indeed, RSA 0-3 h survival rates differ substantially between parasite isolates with wild-type (median 0.17%, range 0.06-0.51%, n 5 16) or mutant (18.8%, 3.8-58%, n 5 33) K13-propeller alleles (P , 10
24
, Mann-Whitney U test) (Supplementary Table 1 ). Four mutant alleles are observed, each harbouring a single non-synonymous SNP within a kelch repeat of the C-terminal K13-propeller domain, namely Y493H, R539T, I543T and C580Y located within repeats no. 2, 3, 3 and 4, respectively. Both the K1992 and the ART-susceptible 89F5 lines carry a wild-type K13-propeller. There are no associations between polymorphisms in the K13-propeller and those in the other candidate genes (Supplementary Table 1 ). Based on these observations and the acquisition of M476I in kelch repeat no. 2 by F32-ART5, we investigated whether K13-propeller polymorphism is a molecular signature of ART resistance in Cambodia.
Emergence and spread of K13-propeller mutants in Cambodia
Over the last decade, the prevalence of ART resistance has steadily increased in the western provinces of Cambodia, but not elsewhere in † * ‡ PF3D7_0110400 PF3D7_1343700 PF3D7_0213400 PF3D7_1115700 PF3D7_1302100 PF3D7_1459600 PF3D7_1464500
24-h drug pressure parasites exposed to increasing artemisinin concentrations for 120 consecutive cycles 18 were analysed by whole-genome sequencing at five time-points (red arrows). Loci mutated after a given number of drug-pressure cycles are shown (red boxes). The earliest time-points where three mutations were detected by PCR (black arrows) are indicated by { for PF3D7_1343700, * for PF3D7_0213400 and { for PF3D7_1115700. Orange and green circles indicate RSA 0-3 h survival rates for F32-ART5 and F32-TEM parasites, respectively (mean of 3 experiments each). (Fig. 3) .
To further investigate the geographic diversity of K13-propeller polymorphism in Cambodia, we extended our sequence analysis to include data from four additional provinces (n 5 55, Kampong Som, Kampot, Mondulkiri and Oddar Meanchey) in 2011-2012 (Extended Data Table 4 ). Although a large number of mutations are observed (Supplementary Fig. 1 and Extended Data Table 5 ), the C580Y allele accounts for 85% (189/222) of all mutant alleles observed in 2011-2012 (Extended Data Fig. 2 ). This mapping outlines the elevated frequency (74%, 222/ 300) of parasites harbouring a single non-synonymous mutation in the K13-propeller and the geographic disparity of their distribution. Importantly, the frequency distribution of mutant alleles over the various provinces matches that of day 3 positivity in patients treated for malaria with an ACT (Spearman's r 5 0.99, 95% confidence interval 0.96-0.99, P , 0.0001), considered a suggestive sign of clinical ART resistance (Extended Data Fig. 3 ).
K13-propeller polymorphisms and clinical ART resistance
To confirm that K13-propeller polymorphism is a molecular marker of clinical ART resistance, we first identified 163 patients from Pursat and Ratanakiri in whom we measured parasite clearance half-lives (range 1.58-11.53 h) 6 in 2009-2010 and for which parasites were previously assigned to a KH subpopulation (KH1, KH2, KH3, KH4 or KHA) on the basis of ancestry analysis of whole-genome sequence data 15 . Thirteen patients with mixed genotypes (a wild-type and one or more mutant K13-propeller alleles) were excluded. Of the remaining 150 patients, 72 carried parasites with a wild-type allele and the others carried parasites with only a single non-synonymous SNP in the K13-propeller: C580Y (n 5 51), R539T (n 5 6) and Y493H (n 5 21) (Extended Data Table 6 ). The parasite clearance half-life in patients with wild-type parasites is significantly shorter (median 3.30 h, interquartile range (IQR) 2.59-3.95) than those with C580Y (7.19 h, 6.47-8.31, P , 10
26
, MannWhitney U test), R539T (6.64 h, 6.00-6.72, P , 10
24
) or Y493H (6.28 h, 5.37-7.14, P , 10
26
) parasites (Fig. 4a) . Also, the parasite clearance half-life in patients carrying C580Y parasites is significantly longer than those with Y493H parasites (P 5 0.007, Mann-Whitney U test). These data indicate that C580Y, R539T and Y493H identify slow-clearing parasites in malaria patients treated with ART.
Because KH2, KH3, KH4 and KHA parasites have longer half-lives than KH1 parasites 15 , we proposed that allelic variation in the K13-propeller accounts for these differences. Among 150 parasites, 55, 26, 14, 12 and 43 are classified as KH1, KH2, KH3, KH4 and KHA, respectively. Three K13-propeller alleles strongly associate with KH groups: 96% (53/55) of KH1, 96% (25/26) of KH2 and 100% (12/12) of KH4 parasites carry the wild-type, C580Y and Y493H alleles, respectively (Extended Data Table 6 ). Whereas KH3 parasites (n 5 14) carry the wild-type, C580Y and R539T alleles, R539T is not observed in KH1, KH2 or KH4 
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parasites. As expected, KHA parasites have a mixed allele composition. Importantly, K13-propeller mutations more accurately identify slowclearing parasites than KH group (Fig. 4b) , demonstrating that the association of K13-propeller polymorphism with clinical ART resistance in Cambodia is partially independent of the genetic background of KH subpopulations. Within the KH1 group (n 5 55), the parasite clearance half-life in patients with wild-type parasites is significantly shorter (n 5 53, median 2.88 h, IQR 2.52-3.79) than those with Y493H parasites (n 5 2, median 6.77 h, P 5 0.02, Mann-Whitney U test). Within the KH3 subpopulation (n 5 14), the half-life in patients with wild-type parasites is shorter (n 5 3, median 3.65 h) than those with C580Y (n 5 7, median 8.73 h, IQR 7.35-9.06, P 5 0.02) or R539T (n 5 4, 6.65 h, 6.29-6.80, P 5 0.03) parasites.
Discussion
The F32-ART5 lineage acquired a K13-propeller mutation as it developed ART resistance, as indicated by its ability to survive a pharmacologically relevant exposure to DHA in the RSA 0-3 h . Genes putatively associated with ART resistance (Pfcrt and Pfubcth-the orthologue of Plasmodium chabaudi ubp1 33, 34 ) were not mutated during the 5-year selection of F32-ART5, and Pfmdr1 amplification was not observed [35] [36] [37] [38] [39] [40] . In addition, all candidate ARTresistance genes recently identified using population genetics approaches 14 ,40,41 remained unaltered in F32-ART5, except for PF3D7_1343700 and PF3D7_1459600 located in the linkage-disequilibrium windows identified in ref. 16 . These findings led us to identify another 17 single K13-propeller mutations in naturally circulating parasites in Cambodia. Several of these mutations associate strongly with the spatiotemporal distribution of ART resistance in Cambodia, increased parasite survival rates in response to DHA in vitro, and long parasite clearance half-lives in response to ART treatment in vivo. None of the six other genes mutated in F32-ART5 associate with RSA 0-3 h survival rates in parasite isolates from Cambodia.
K13-propeller polymorphism fulfils the definition of a molecular marker of ART resistance for several reasons: (1) there has been a progressive loss of wild-type parasites in western Cambodia during the decade of emerging ART resistance in this region; (2) mutant parasites cluster in Cambodian provinces where ART resistance is well established and are less prevalent where ART resistance is uncommon; (3) PF3D7_1343700 is located 5.9 kilobases upstream of the 35-kb locus identified in ref. 14 as being under recent positive selection, and within the region of top-ranked signatures of selection outlined in ref. 16 ; (4) multiple mutations, all non-synonymous, are present in the K13-propeller, reflecting positive selection rather than a hitchhiking effect or genetic drift; (5) mutations occur in a domain that is highly conserved in P. falciparum, with only one non-synonymous SNP being documented in a single parasite isolate from Africa 42 ; (6) all polymorphisms we observe in Cambodia are novel and all but one (V568G) occur at positions strictly conserved between Plasmodium species (Supplementary Fig. 1 and Supplementary Fig. 2 ), suggesting strong structural and functional constraints on the protein; (7) the three most-prevalent K13-propeller mutations correlate strongly with RSA 0-3 h survival rates in vitro and parasite clearance half-lives in vivo at the level of individual parasite isolates and malaria patients, respectively; and (8) the frequency of mutant alleles correlates strongly with the prevalence of day 3 positivity after ACT treatment at the level of human populations in Cambodia.
On the basis of homology with other kelch propeller domains, we anticipate that the observed K13-propeller mutations destabilize the domain scaffold and alter its function. The carboxy-terminal portion of PF3D7_1343700 encodes six kelch motifs, which are found in a large number of proteins with diverse cellular functions 43, 44 . Given that the toxicity of ART derivatives depends principally on their pro-oxidant activity, the reported role of some kelch-containing proteins in regulating cytoprotective and protein degradation responses to external stress is particularly intriguing. The K13-propeller shows homology with human KLHL12 and KLHL2, involved in ubiquitin-based protein degradation, and KEAP1, involved in cell adaptation to oxidative stress (Extended Data Fig. 4 ). More work is needed to delineate the normal function of K13 and the effect of various mutations. Allele exchange studies in mutant and wild-type parasites may help to define the contribution of K13-propeller polymorphisms on different genetic backgrounds to the RSA 0-3 h survival rate. Indeed, it is particularly worrying that as few as two mutations, that is, the K13-propeller M476I and PF3D7_0110400 D56V, were sufficient to confer ART resistance to F32-Tanzania, which has a typical African genetic background. Cambodian parasites with mutant K13-propellers display a wide range of RSA 0-3 h survival rates (3.8-58%) and parasite clearance half-lives (4.5-11.5 h). Further studies are therefore required to identify additional genetic determinants of ART resistance, which may reside in the strongly selected regions recently identified 14, 16 . In this context, analysing the RSA 0-3 h survival rates as a quantitative trait among parasites harbouring the same K13-propeller mutation could help to identify additional genetic loci involved in ART resistance. 
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, MannWhitney U test), R539T (6.64 h, 6.00-6.72, n 5 6, P , 10
) or Y493H (6.28 h, 5.37-7.14, n 5 21, P , 10
) parasites. The half-life of C580Y parasites is significantly longer than that of Y493H parasites (P 5 0.007). b, Correlation of parasite clearance half-lives, KH subpopulations 15 and K13-propeller alleles for the same 150 parasite isolates. Half-lives are shown for Pursat (squares) and Ratanakiri (triangles) parasites, stratified by KH group and K13-propeller allele (colour-coded as in a). Median half-lives stratified by K13-propeller allele are KH1: wild type (2.88) and Y493H (6.77); KH2: C580Y (7.13) and Y493H (4.71); KH3: wild type (3.65), C580Y (8.73) and R539T (6.65); KH4: Y493H (6.37); and KHA: wild type (4.01), C580Y (7.09), Y493H (6.18) and R539T (5.73).
ARTICLE RESEARCH
In summary, K13-propeller polymorphism seems to be a useful molecular marker for tracking the emergence and spread of ARTresistant P. falciparum.
METHODS SUMMARY
The ART-resistant F32-ART5 parasite line was selected by culturing the ARTsensitive F32-Tanzania clone under a dose-escalating regimen of artemisinin for 5 years. The F32-TEM line was obtained by culturing F32-Tanzania in parallel without artemisinin exposure. Reference DNA was extracted from P. falciparum lines 3D7, 89F5 Palo Alto Uganda and K1992. The ring-stage survival assay (RSA 0-3 h ) was performed as described previously 13 . Whole-genome sequencing was performed on F32-Tanzania, F32-TEM, F32-ART5 (4 time points), three reference strains (3D7, 89F5 and K1992) and 21 Cambodian parasite isolates, using an Illumina paired-reads sequencing technology. A set of 1091 clinical P. falciparum isolates was collected from patients participating in ACT efficacy studies in 2001-2012. The K13-propeller was amplified using nested PCR. Double-strand sequencing of PCR products was performed by Macrogen. Sequences were analysed with MEGA 5 software version 5.10 to identify specific SNP combinations. Supplementary Information is available in the online version of the paper. Parasite cultures were maintained at 37 uC in an atmosphere of 5% CO 2 . Parasitaemia was checked daily and maintained below 10%. For the selection of ART-resistant parasites, asynchronous cultures were adjusted to 5-7% parasitaemia and grown in the presence of escalating doses of artemisinin (from 10 nM to 9 mM) for 24 h for the first 3 years of drug pressure 18 . In the subsequent 2 years, each drug-pressure cycle was done for 48 h with doses ranging from 9 mM to 18 mM. After drug exposure, the medium was discarded and replaced by human-serum-supplemented (20%) drug-free medium. Parasitaemia was monitored daily until it reached 5%. At that time, drug pressure was reapplied. The parasite line obtained after an effective 5 years of discontinuous ART pressure was named F32-ART5. In parallel, the parental F32-Tanzania line was kept as a control in continuous culture for the same time under the same conditions (that is, RBCs, serum and media) but without artemisinin exposure. The resulting control line was called F32-TEM. Laboratory-adapted P. falciparum lines. Reference DNA was extracted from the laboratory-adapted P. falciparum lines 3D7 (MR4, Manassas, VA), 89F5 Palo Alto Uganda (a clone from the Palo Alto line, originating from Uganda in 1978, which displayed high susceptibility to artemether treatment in the Saimiri sciureus experimental host (O. Mercereau-Puijalon, H. Contamin and J.-C. Barale, unpublished data)) and K1992, an isolate collected in Pailin in 1992 before the mass deployment of ART in that area (provided by the French National Reference Center of Malaria). Parasite DNA was extracted from frozen blood aliquots (200 ml) using the Mini blood kit (Qiagen) according to the manufacturer's instructions. Culture-adapted P. falciparum isolates from Cambodia. Fifty clinical P. falciparum isolates from Cambodia (collected in 2010 and 2011) were adapted to in vitro culture as described in ref. 45 . Their geographic origin is indicated in Supplementary  Table 1 . Parasite clearance rates were not determined for these patient isolates, as they were collected during field trials that did not include such measurements. Parasite DNA was extracted from frozen blood aliquots (200 ml) using the Mini blood kit (Qiagen). Ring-stage survival assay. The ring-stage survival assay (RSA 0-3 h ) was carried out as described in ref. 13 using highly synchronous parasite cultures. In brief, 0-3 h post-invasion ring-stage parasites were exposed to 700 nM DHA (dihydroartemisinin, obtained from WWARN (http://www.wwarn.org/research/tools/ qaqc)) or its solvent DMSO for 6 h, washed and then cultivated for the next 66 h without drug. Survival rates were assessed microscopically by counting in Giemsastained thin smears the proportion of viable parasites that developed into secondgeneration rings or trophozoites with normal morphology. Ethical clearance. Ethical clearances for the collection of parasite isolates from patients were obtained from the Cambodian National Ethics Committee for Health Research, the Institutional Review Board of the Naval Medical Research Center, the Technical Review Group of the WHO Regional Office for the Western Pacific, and the Institutional Review Board of the National Institute of Allergy and Infectious Diseases. Work was conducted in compliance with all relevant ethical standards and regulations governing research involving human subjects. Written informed consent was obtained from all adult participants or the parents or guardians of children. Temporal and geographical sample collection. A set of 941 clinical P. falciparum isolates was collected from patients participating in therapeutic efficacy studies of ACTs, conducted as part of the routine antimalarial drug efficacy monitoring of Cambodia's National Malaria Control Program from 2001 to 2012, and from studies conducted by NAMRU-2 (Extended Data Table 4 ). Venous blood samples (5 ml) collected in EDTA or ACD were transported to Institut Pasteur du Cambodge in Phnom Penh within 48 h of collection at 4 uC and then kept at 220 uC until DNA extraction. Parasite DNA was extracted from frozen blood aliquots (200 ml) using the Mini blood kit (Qiagen). Measurement of parasite clearance half-life. Patients with uncomplicated or severe P. falciparum malaria and initial parasite density $ 10,000 ml 21 were enrolled in Pursat and Ratanakiri provinces in 2009 and 2010 as described 6, 13 . Patients were treated with an ART and their parasite density measured every 6 h from thick blood films until parasitaemia was undetectable. The parasite clearance half-life in 163 patients was derived from these parasite counts using WWARN's on-line Parasite Clearance Estimator (http://www.wwarn.org/toolkit/data-management/ parasite-clearance-estimator). The study is registered at ClinicalTrials.gov (number NCT00341003). Whole-genome sequencing of parasite DNA. Whole-genome sequencing was performed on F32-Tanzania, F32-TEM, the F32-ART5 lineage (4 time-points), three reference strains (3D7, 89F5 and K1992) and 21 parasite isolates from Cambodia, using an Illumina paired-reads sequencing technology. Illumina library preparation and sequencing followed standard protocols developed by the supplier. Briefly, genomic DNA was sheared by nebulization, and sheared fragments were endrepaired and phosphorylated. Blunt-end fragments were A-tailed, and sequencing adapters were ligated to the fragments. Inserts were sized using Agencourt AMPure XP Beads (6 500 bp; Beckman Coulter Genomics) and enriched using 10 cycles of PCR before library quantification and validation. Hybridization of the library to the flow cell and bridge amplification was performed to generate clusters, and paired-end reads of 100 cycles were collected on a HiSeq 2000 instrument (Illumina). After sequencing was complete, image analysis, base calling and error estimation were performed using Illumina Analysis Pipeline version 1.7.
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Raw sequence files were filtered using Fqquality tool, a read-quality filtering software developed by N. Joly, which enables the trimming of the first and last low-quality bases in reads. The trimmed reads from controlled Fastq files were mapped on a reference genome (P. falciparum 3D7) with the Burrows-Wheeler Alignment (BWA), generating a BAM file (a binary file of tab-delimited format SAM). Next, we used Samtools to prepare a pileup file, which was formatted using in-house software to implement the data into the Wholegenome Data Manager (WDM) database (Beghain et al., in preparation). WDM software is designed to compare and/or align partial or whole P. falciparum genomes. Sequencing genes containing non-synonymous SNPs in F32-ART5. PCR amplification of selected genes was performed using the primers listed in Extended Data Table 1 . Two ml of DNA was amplified with 1 mM of each primer, 0.2 mM dNTP (Solis Biodyne), 3 mM MgCl 2 and 2 U Taq DNA polymerase (Solis Biodyne), using the following cycling program: 5 min at 94 uC, then 40 cycles of 30 s at 94 uC, 90 s at 60 uC, 90 s at 72 uC and final extension 10 min at 72 uC. PCR products were detected by 2% agarose gel electrophoresis and ethidium bromide staining. Doublestrand sequencing of PCR products was performed by Beckman Coulter Genomics. Sequences were analysed with MEGA 5 software version 5.10 in order to identify specific SNP combinations. Sequencing the K13-propeller domain. The K13-propeller domain was amplified using the following primers: for the primary PCR (K13-1 59-cggagtgaccaaatctggga-39 and K13-4 59-gggaatctggtggtaacagc-39) and the nested PCR (K13-2 59-gccaagctg ccattcatttg -39 and K13-3 59-gccttgttgaaagaagcaga -39). One ml of DNA was amplified with 1 mM of each primer, 0.2 mM dNTP (Solis Biodyne), 3 mM MgCl 2 and 2 U Taq DNA polymerase (Solis Biodyne), using the following cycling program: 5 min at 94 uC, then 40 cycles of 30 s at 94 uC, 90 s at 60 uC, 90 s at 72 uC and final extension 10 min at 72 uC. For the nested PCR, 2 ml of primary PCR products were amplified under the same conditions, except for the MgCl 2 concentration (2.5 mM). PCR products were detected using 2% agarose gel electrophoresis and ethidium bromide staining. Double-strand sequencing of PCR products was performed by Macrogen. Sequences were analysed with MEGA 5 software version 5.10 to identify specific SNP combinations. Deep-sequencing of clinical parasite isolates and population structure analysis. DNA extraction, Illumina sequencing and SNP genotyping of clinical parasite isolates obtained from malaria patients in Pursat and Ratanakiri provinces, Cambodia, have been previously described 15 . Population structure analysis of these parasites identified four subpopulations: KH1, KH2, KH3 and KH4. Parasites with ,80% ancestry from any of these four groups were deemed admixed (KHA). Temporal acquisition of mutations in the F32-ART5 lineage. The F32-ART5 lineage was explored by whole-genome sequencing using samples collected at time 0 (original F32-Tanzania clonal line), day 196 (0.2-mM pressure cycle no. 23), day 385 (1.8-mM pressure cycle no. 39), day 618 (9-mM pressure cycle no. 56) and day 2,250 (9-mM pressure cycle no. 120). The F32-TEM sample was collected on day 2,250. Additional samples collected at the time of the 30th, 33rd, 34th, 36th, 68th and 98th pressure cycles were studied by PCR. DNA from parasite cultures was extracted using the High Pure PCR Template Preparation Kit (Roche Diagnostics) according to the manufacturer's instructions.
The F32-ART5 samples tested in the ring-stage survival assay (RSA 0-3 h ) were collected at the time of the 17th, 48th and 122nd pressure cycles (0.04, 2.7 and 9 mM ART), respectively. The F32-TEM sample was collected at the last mock pressure cycle. The RSA 0-3 h survival rates were determined in triplicate experiments with different batches of red blood cells, and evaluated as above using Giemsa-stained thin smears read by two independent microscopists (B.W. and F.B.-V.). Survival rates were compared using Mann-Whitney U test. The RSA 0-3 h survival rates of the F32-ART5 samples were as follows: at drug-pressure cycles: no. ) indicating its rapid invasion of the population and near fixation in these provinces. Three-dimensional structure modelling of the K13-propeller. The 3D-structural model of the kelch propeller domain of PF3D7_1343700 ('K13-propeller') was obtained by homology modelling satisfying spatial restraints using Modeller v9.11 (http://modbase.compbio.ucsf.edu). The 295 amino acids composing the K13-propeller are 22%, 25% and 25% identical to the kelch propeller domain of the human KEAP1 (Protein Data Bank (PDB; http://www.rcsb.org/) 2FLU), KLHL12 (PDB 2VPJ) and KLHL2 (PDB 2XN4) proteins, respectively, that were used as templates to model the 3D-structure of the K13-propeller. The reliability of the obtained model was assessed using two classical criteria. First, the significance of the sequence alignment between the K13-propeller domain and one template was confirmed by an E-value 5 0, as calculated by Modeller using the Built-Profile routine. Second, the model achieved a GA341 model score 5 1 (a score $ 0.7 corresponds to highly reliable models). Localization of the mutants in the K13-propeller 3D-model was prepared using the PyMOL Molecular Graphics System, version 1.5.0.4 (Schrödinger; http://www.pymol.org). Statistical analysis. Data were analysed with Microsoft Excel and MedCalc version 12. Quantitative data were expressed as median, interquartile range (IQR). The Mann-Whitney U test (independent samples, two-sided) was used to compare two groups, and the Kruskal-Wallis test (H-test, two-sided) was used to compare more than two groups. The Spearman's rho rank correlation coefficient (and the 95% confidence interval for the correlation coefficient) was used to measure the strength of relationship between the prevalence of wild-type K13-propeller allele and the frequency of day 3 positivity (defined as persistence of microscopically detectable parasites on the third day of artemisinin-based combination therapy) 2 . Fisher's exact test was used to compare frequency data and the Clopper-Pearson exact method based on the beta distribution was used to determine 95% confidence intervals for proportions. Differences were considered statistically significant when P values were less than 0.05. Figure 
Extended Data

ARTICLE RESEARCH
Extended Data Figure 4 | Schematic representation of homology between P. falciparum K13 and human KEAP1 proteins and structural 3D model of the K13-propeller domain. a, Schematic representation of the predicted PF3D7_1343700 protein and homology to human KEAP1. Similar to KEAP1, PF3D7_1343700 contains a BTB/POZ domain and a C-terminal 6-blade propeller, which assembles kelch motifs consisting of four anti-parallel beta sheets. b, Structural 3D model of the K13-propeller domain showing the six kelch blades numbered 1 to 6 from N to C terminus and colour-coded as in Supplementary Fig. 1 . The level of amino-acid identity between the K13-propeller and kelch domains of proteins with solved 3D structures, including human KEAP1 46, 47 , enabled us to model the 3D structure of the K13-propeller and to map the mutations selected under ART pressure (Extended data Table 5 ). The accuracy of the K13-propeller 3D model was confirmed by Modeller-specific model/fold criteria of reliability (see Methods). We predict that the K13-propeller folds into a 6-bladed b-propeller structure 48 closed by the interaction between a C-terminal beta-sheet and the N-terminal blade 46, 48 . The first domain has three b-sheets, the fourth one being contributed by an extra C-terminal b-sheet called b'1 in Supplementary Fig. 1 . The human KEAP1 kelch propeller scaffold is destabilized by a variety of mutations affecting intra-or inter-blade interactions in human lung cancer 46 and hypertension 47 . The positions of the various mutations are indicated by a sphere, colour-coded as in Figs 2-4 . The M476 residue mutated in F32-ART5 is indicated in dark grey. Like the mutations observed in human KEAP1 46, 47 , many K13-propeller mutations are predicted to alter the structure of the propeller or modify surface charges, and as a consequence alter the biological function of the protein. Importantly, the two major mutations C580Y (red) and R539T (blue) observed in Cambodia are both non-conservative and located in organized secondary structures: a b-sheet of blade 4 where it is predicted to alter the integrity of this scaffold and at the surface of blade 3, respectively. The kelch propeller domain of KEAP1 is involved in protein-protein interactions like most kelch containing modules 43 . KEAP1 is a negative regulator of the inducible Nrf2-dependent cytoprotective response, sequestering Nrf2 in the cytoplasm under steady state. Upon oxidative stress, the Nrf2/KEAP1 complex is disrupted, and Nrf2 translocates to the nucleus, where it induces transcription of cytoprotective ARE-dependent genes 49, 50 . We speculate that similar functions may be performed by PF3D7_1343700 in P. falciparum, such that mutations of the K13-propeller impair its interactions with an unknown protein partner, resulting in a deregulated anti-oxidant/cytoprotective response. The P. falciparum anti-oxidant response is maximal during the late trophozoite stage, when haemoglobin digestion and metabolism are highest 51 . Its regulation is still poorly understood and no Nrf2 orthologue could be identified in the Plasmodium genome.
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